← United States · Coverage record
US · SEC FORM 4
VOLITIONRX LTD
VNRX · NYSE · CIK 0000093314 · Healthcare · Medical Devices
INSIDER SIGNAL
0 qualifying P purchase groups
in the current 180-day scoring window
2 Form 4 transaction lines observed in the same window
0 sales · 2 option, withholding, award, gift or other lines
WHY NO ACTIVE SIGNAL?
Score anatomy
No score is calculated because there is no qualifying purchase in the active window. Unavailable inputs are not treated as zero or as a bearish signal.
Why is there no score?
- No qualifying open-market purchase supplies cluster, size, role, recency or conviction inputs.
- Sales and other Form 4 activity remain visible as context and do not create a negative score.
Sales and other Form 4 activity are shown separately and do not create a negative buy signal. Absence of buying is not scored as bearish.
Insider activity timeline
Owner lanes show the latest 180 days. Symbol shape identifies the transaction type; sales remain context only.
—
Purchase breadth, concentration & cluster buying
These modules activate when qualifying purchases enter the 180-day research window.
SIGNAL HISTORY
Scores are archived only when the company qualifies for a published US buy-signal snapshot. Last qualifying purchase: 2025-11-17 · Reynolds Cameron John.
Recent Form 4 activity
P is an open-market or private purchase. S is a sale. M, F, A and G usually describe exercises, tax withholding, awards and gifts. These categories remain visually separate.
Market context
Market context has not been captured for this ticker yet. The daily market-context job processes the US universe in rotating batches.
Short interest
Short interest is external context reported to FINRA by broker-dealers. It does not affect the Insider Signal.
- Shares short
- 1,196,849
- Previous report
- 1,004,963
- Avg daily volume
- 4,427,440
- Days to cover
- ≤ 1.0
FINRA settlement date: 2026-09-30 · Captured 2026-10-12 · FINRA equity short interest ↗. A share count, published about a week after each of two settlement dates a month; not a percentage of shares outstanding.
Historical equity purchases
Qualifying code P transactions in the local Form 4 history, including purchases outside the current signal window.
| Transaction date | Reporting owner | Type | Security | Shares | Avg. price | Approx. value | Source |
|---|---|---|---|---|---|---|---|
| 2025-11-17 | Reynolds Cameron John | Purchase (P) | Common Stock | 20,000 | USD 0.35 | USD 7,000 | SEC filing ↗ |
| 2025-10-14 | STILL TIMOTHY I | Purchase (P) | Common Stock | 48,076 | USD 0.51 | USD 24,519 | SEC filing ↗ |
| 2025-10-14 | Reynolds Cameron John | Purchase (P) | Common Stock | 110,000 | USD 0.51 | USD 56,100 | SEC filing ↗ |
| 2025-10-14 | Innes Guy Archibald | Purchase (P) | Common Stock | 96,153 | USD 0.51 | USD 49,038 | SEC filing ↗ |
| 2025-09-12 | Reynolds Cameron John | Purchase (P) | Common Stock | 15,000 | USD 0.66 | USD 9,900 | SEC filing ↗ |
| 2025-08-05 | Reynolds Cameron John | Purchase (P) | Common Stock | 78,125 | USD 0.64 | USD 50,000 | SEC filing ↗ |
| 2025-08-05 | Innes Guy Archibald | Purchase (P) | Common Stock | 78,125 | USD 0.64 | USD 50,000 | SEC filing ↗ |
| 2025-06-12 | Reynolds Cameron John | Purchase (P) | Common Stock | 12,500 | USD 0.59 | USD 7,375 | SEC filing ↗ |
| 2025-06-03 | Innes Guy Archibald | Purchase (P) | Common Stock | 20,000 | USD 0.54 | USD 10,800 | SEC filing ↗ |
| 2025-05-19 | Reynolds Cameron John | Purchase (P) | Common Stock | 20,000 | USD 0.44 | USD 8,800 | SEC filing ↗ |
| 2025-05-19 | Micallef Jacob Vincent | Purchase (P) | Common Stock | 50,000 | USD 0.43 | USD 21,500 | SEC filing ↗ |
| 2025-03-26 | Reynolds Cameron John | Purchase (P) | Common Stock | 181,818 | USD 0.55 | USD 100,000 | SEC filing ↗ |
| 2025-03-26 | Innes Guy Archibald | Purchase (P) | Common Stock | 181,818 | USD 0.55 | USD 100,000 | SEC filing ↗ |
| 2024-12-09 | STILL TIMOTHY I | Purchase (P) | Common Stock | 87,382 | USD 0.57 | USD 49,808 | SEC filing ↗ |
| 2024-12-09 | Reynolds Cameron John | Purchase (P) | Common Stock | 139,811 | USD 0.57 | USD 79,692 | SEC filing ↗ |
Form 4 evidence
45 transaction lines in the latest 365-day window; 431 in local history.
| Date | Owner | Type | Security | Shares | Avg. price | Approx. value | Source |
|---|---|---|---|---|---|---|---|
| 2026-09-28 | Michel Gaetan | Tax withholding (F) | Common Stock | 608 | USD 0.25 | USD 152 | SEC filing ↗ |
| 2026-09-28 | Forterre Gael | Tax withholding (F) | Common Stock | 284 | USD 0.25 | USD 71 | SEC filing ↗ |
| 2026-03-17 | Rootsaert Rodney Gerard | Tax withholding (F) | Common Stock | 3,948 | USD 0.19 | USD 750 | SEC filing ↗ |
Show recent Form 4 evidence (30 grouped rows)
| Date | Owner | Type | Security | Shares | Avg. price | Approx. value | Source |
|---|---|---|---|---|---|---|---|
| 2026-09-28 | Michel Gaetan | Tax withholding (F) | Common Stock | 608 | USD 0.25 | USD 152 | SEC filing ↗ |
| 2026-09-28 | Forterre Gael | Tax withholding (F) | Common Stock | 284 | USD 0.25 | USD 71 | SEC filing ↗ |
| 2026-03-17 | Rootsaert Rodney Gerard | Tax withholding (F) | Common Stock | 3,948 | USD 0.19 | USD 750 | SEC filing ↗ |
| 2026-03-17 | Plummer Nicholas | Tax withholding (F) | Common Stock | 7,003 | USD 0.19 | USD 1,331 | SEC filing ↗ |
| 2026-03-17 | Micallef Jacob Vincent | Tax withholding (F) | Common Stock | 5,310 | USD 0.19 | USD 1,009 | SEC filing ↗ |
| 2026-03-17 | Forterre Gael | Tax withholding (F) | Common Stock | 5,251 | USD 0.19 | USD 998 | SEC filing ↗ |
| 2026-03-01 | Rootsaert Rodney Gerard | Tax withholding (F) | Common Stock | 3,321 | USD 0.21 | USD 697 | SEC filing ↗ |
| 2026-03-01 | Plummer Nicholas | Tax withholding (F) | Common Stock | 5,867 | USD 0.21 | USD 1,232 | SEC filing ↗ |
| 2026-03-01 | Forterre Gael | Tax withholding (F) | Common Stock | 2,283 | USD 0.21 | USD 479 | SEC filing ↗ |
| 2026-02-26 | Rubin Ethel | Award / grant (A) | Common Stock | 178,000 | USD 0.00 | USD 0 | SEC filing ↗ |
| 2026-02-26 | Rootsaert Rodney Gerard | Award / grant (A) | Common Stock | 119,000 | USD 0.00 | USD 0 | SEC filing ↗ |
| 2026-02-26 | Reynolds Cameron John | Award / grant (A) | Common Stock | 486,000 | USD 0.00 | USD 0 | SEC filing ↗ |
| 2026-02-26 | Plummer Nicholas | Award / grant (A) | Common Stock | 187,000 | USD 0.00 | USD 0 | SEC filing ↗ |
| 2026-02-26 | Nguyen Kim | Award / grant (A) | Common Stock | 178,000 | USD 0.00 | USD 0 | SEC filing ↗ |
| 2026-02-26 | Micallef Jacob Vincent | Award / grant (A) | Common Stock | 149,000 | USD 0.00 | USD 0 | SEC filing ↗ |
| 2026-02-26 | Kway Jasmine | Award / grant (A) | Common Stock | 173,000 | USD 0.00 | USD 0 | SEC filing ↗ |
| 2026-02-26 | Innes Guy Archibald | Award / grant (A) | Common Stock | 178,000 | USD 0.00 | USD 0 | SEC filing ↗ |
| 2026-02-26 | Hughes Terig | Award / grant (A) | Common Stock | 202,000 | USD 0.00 | USD 0 | SEC filing ↗ |
| 2026-02-26 | Forterre Gael | Award / grant (A) | Common Stock | 149,000 | USD 0.00 | USD 0 | SEC filing ↗ |
| 2026-02-26 | Batchelor Ann-Louise | Award / grant (A) | Common Stock | 142,000 | USD 0.00 | USD 0 | SEC filing ↗ |
| 2026-02-01 | Rootsaert Rodney Gerard | Tax withholding (F) | Common Stock | 3,196 | USD 0.29 | USD 927 | SEC filing ↗ |
| 2026-02-01 | Plummer Nicholas | Tax withholding (F) | Common Stock | 5,647 | USD 0.29 | USD 1,638 | SEC filing ↗ |
| 2026-02-01 | Forterre Gael | Tax withholding (F) | Common Stock | 2,010 | USD 0.29 | USD 583 | SEC filing ↗ |
| 2026-01-22 | STILL TIMOTHY I | Award / grant (A) | Common Stock | 90,000 | USD 0.00 | USD 0 | SEC filing ↗ |
| 2026-01-22 | Rubin Ethel | Award / grant (A) | Common Stock | 12,000 | USD 0.00 | USD 0 | SEC filing ↗ |
| 2026-01-22 | Rootsaert Rodney Gerard | Award / grant (A) | Common Stock | 28,200 | USD 0.00 | USD 0 | SEC filing ↗ |
| 2026-01-22 | Reynolds Cameron John | Award / grant (A) | Common Stock | 74,700 | USD 0.00 | USD 0 | SEC filing ↗ |
| 2026-01-22 | Plummer Nicholas | Award / grant (A) | Common Stock | 44,700 | USD 0.00 | USD 0 | SEC filing ↗ |
| 2026-01-22 | Nguyen Kim | Award / grant (A) | Common Stock | 12,000 | USD 0.00 | USD 0 | SEC filing ↗ |
| 2026-01-22 | Micallef Jacob Vincent | Award / grant (A) | Common Stock | 35,400 | USD 0.00 | USD 0 | SEC filing ↗ |
Multiple price lines in one filing are grouped and share-weighted. Price and value are blank when a grouped filing line lacks price evidence.
Snapshot & identity
| Snapshot date | 2026-10-18 |
|---|---|
| Ranking version | US-v1.2 |
| Data quality | PASS ELIGIBLE · — |
| Ticker | VNRX |
| CIK | 0000093314 |
| Sector | Healthcare |
| Industry | Medical Devices Yahoo Finance |
| SEC SIC | 2835 In Vitro & In Vivo Diagnostic Substances |
| Exchange | NYSE |
Data coverage
| Local Form 4 history | 431 transaction lines from 2020-01-12 to 2026-09-28 61 P purchase lines · 12 S sale lines · 358 other lines |
|---|---|
| SEC company submissions | Open SEC filings ↗ |
Local ledger as of 2026-10-18. Mapping status is an audit field and does not erase SEC filing evidence.